课题基金 / 基金详情

Trial Designs Using Direct Pateint Reporting of Post Market Outcome; The Motherisk Model for Fetal Safety of Opioids

Trial Designs Using Direct Pateint Reporting of Post Market Outcome; The Motherisk Model for Fetal Safety of Opioids
使用直接患者报告上市后结果的试验设计；
批准号：
327722
负责人：
Koren Gideon
金额：
$6.99万
依托单位：
Hospital for Sick Children (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-01-01 至 2016-01-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=327722&lang=en
关键词：
Chronic Pain Malformations Maternal Age Miscarriages Motherisk Opioids Pregnancy Prematurity Prospective Cohort Stillbirth

项目摘要

项目成果

Koren Gideon的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Koren G: Trial Designs Using Direct Patient Reporting of Post Market Outcome; The Motherisk Model for Fetal Safety of Opioids The objectives of this DSEN project is to test the feasibility of direct reporting of opioid use during the first trimester of pr
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the safety of codeine use in young children after adenotonsillectomy for obstructive sleep apnea syndrome
The Neonatal Safety of Breastfeeding During Maternal Use of Opioid Analgesics
海外基金